Christophe De Block

Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes

Bart Keymeulen, Evy Vandemeulebroucke, Anette G. Ziegler et al. · New England Journal of Medicine · 2005 · 1.1K citations · Full text

Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass

Bart Keymeulen, Melanie Walter, Chantal Mathieu et al. · Diabetologia · 2010 · 310 citations · Full text

Obesity, Metabolic Syndrome, Diabetes Management +12

Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study

Sara Charleer, Christophe De Block, Liesbeth Van Huffel et al. · Diabetes Care · 2019 · 252 citations · Full text

Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study

Sara Charleer, Chantal Mathieu, Frank Nobels et al. · The Journal of Clinical Endocrinology & Metabolism · 2018 · 185 citations · Full text

Microbiome-derived ethanol in nonalcoholic fatty liver disease

Abraham S. Meijnikman, Mark Davids, Hilde Herrema et al. · Nature Medicine · 2022 · 185 citations

Metabolic Associated Steatohepatitis, Hepatology, Metabolic Associated Steatotic Liver Disease +9